HIV Prevention Trials Network Ethics Working Group / Amgen / Leviton LC / Genentech / Bristol Myers Squibb / / /
Facility
Berman Institute of Bioethics / Durham VA Medical Center / Johns Hopkins University / Duke University Medical Center / /
IndustryTerm
healthcare system / clinical research protocol / HIV Prevention / care for their relative stage in disease / http /
MedicalCondition
hypothetical rheumatoid arthritis / advanced disease / onset rheumatoid arthritis / inflammatory arthritis / HIV / tumour necrosis / disease / arthritis / early inflammatory arthritis / rheumatoid arthritis / serious disease / early rheumatoid arthritis / less severe disease / Very recent onset arthritis / pain / /
MedicalTreatment
clinical research protocol / placebos / /
Organization
Johns Hopkins Medical Institutions Institutional Review Board / Durham VA Medical Center / Berman Institute of Bioethics / Johns Hopkins University School of Medicine / Division of Rheumatology and Immunology / Division of Rheumatology / Johns Hopkins University / Department of Health Policy and Management / Duke University Medical Center / /
Person
Jeremy Sugarman / Holly A Taylor / David S Pisetsky / Ann Rheum Dis / Ann Rheum / Joan Bathon / Van Aken / /
ProvinceOrState
Maryland / North Carolina / /
Technology
research protocol / clinical research protocol / DSP / pdf / /
542 CONCISE REPORT Formative research in clinical trial development: attitudes of patients with arthritis in enhancing prevention trials